rs3741918

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002046.7(GAPDH):​c.29+229T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.204 in 759,242 control chromosomes in the GnomAD database, including 16,848 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 3655 hom., cov: 33)
Exomes 𝑓: 0.20 ( 13193 hom. )

Consequence

GAPDH
NM_002046.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.660

Publications

8 publications found
Variant links:
Genes affected
GAPDH (HGNC:4141): (glyceraldehyde-3-phosphate dehydrogenase) This gene encodes a member of the glyceraldehyde-3-phosphate dehydrogenase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The encoded protein has additionally been identified to have uracil DNA glycosylase activity in the nucleus. Also, this protein contains a peptide that has antimicrobial activity against E. coli, P. aeruginosa, and C. albicans. Studies of a similar protein in mouse have assigned a variety of additional functions including nitrosylation of nuclear proteins, the regulation of mRNA stability, and acting as a transferrin receptor on the cell surface of macrophage. Many pseudogenes similar to this locus are present in the human genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.362 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAPDHNM_002046.7 linkc.29+229T>A intron_variant Intron 2 of 8 ENST00000229239.10 NP_002037.2 P04406-1V9HVZ4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAPDHENST00000229239.10 linkc.29+229T>A intron_variant Intron 2 of 8 1 NM_002046.7 ENSP00000229239.5 P04406-1

Frequencies

GnomAD3 genomes
AF:
0.215
AC:
32704
AN:
152024
Hom.:
3649
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.225
Gnomad AMI
AF:
0.205
Gnomad AMR
AF:
0.218
Gnomad ASJ
AF:
0.0877
Gnomad EAS
AF:
0.375
Gnomad SAS
AF:
0.125
Gnomad FIN
AF:
0.228
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.209
Gnomad OTH
AF:
0.192
GnomAD4 exome
AF:
0.201
AC:
122172
AN:
607098
Hom.:
13193
Cov.:
8
AF XY:
0.197
AC XY:
60628
AN XY:
308154
show subpopulations
African (AFR)
AF:
0.218
AC:
2649
AN:
12162
American (AMR)
AF:
0.217
AC:
2910
AN:
13390
Ashkenazi Jewish (ASJ)
AF:
0.0922
AC:
1225
AN:
13288
East Asian (EAS)
AF:
0.312
AC:
8050
AN:
25784
South Asian (SAS)
AF:
0.119
AC:
5144
AN:
43102
European-Finnish (FIN)
AF:
0.230
AC:
6400
AN:
27818
Middle Eastern (MID)
AF:
0.0908
AC:
209
AN:
2302
European-Non Finnish (NFE)
AF:
0.204
AC:
89585
AN:
439028
Other (OTH)
AF:
0.199
AC:
6000
AN:
30224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4527
9054
13581
18108
22635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2152
4304
6456
8608
10760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.215
AC:
32725
AN:
152144
Hom.:
3655
Cov.:
33
AF XY:
0.213
AC XY:
15868
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.225
AC:
9327
AN:
41532
American (AMR)
AF:
0.217
AC:
3327
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0877
AC:
304
AN:
3468
East Asian (EAS)
AF:
0.376
AC:
1940
AN:
5156
South Asian (SAS)
AF:
0.125
AC:
601
AN:
4826
European-Finnish (FIN)
AF:
0.228
AC:
2423
AN:
10606
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.209
AC:
14186
AN:
67944
Other (OTH)
AF:
0.189
AC:
399
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1351
2703
4054
5406
6757
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.213
Hom.:
449
Bravo
AF:
0.218
Asia WGS
AF:
0.242
AC:
841
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
3.0
DANN
Benign
0.58
PhyloP100
-0.66
PromoterAI
-0.071
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3741918; hg19: chr12-6644256; API